Download full report with analyst certification and important disclosures
Jan 19 2022, 07:35 GMT
Science in Sport (SIS)’ pre-close trading update highlights strong operating momentum and underscores the health of active nutrition category growth. Notwithstanding interminable supply chain challenges, performance was ahead of expectations, with full-year revenues growing 25% and EBITDA doubling to £2.2m. Margin progression was anchored by operating (supply chain) efficiencies, the continued shift online, new product innovation and pricing. A premium brand strategy and favourable gross margin profile offer important levers for SIS to mitigate cost inflation.
Jan 19 2022, 07:35 GMT